<DOC>
	<DOCNO>NCT00538655</DOCNO>
	<brief_summary>Patients treat methamphetamine dependence high rate relapse , pharmacotherapy yet demonstrate efficacious . Modafinil ( , l-2- [ ( diphenylmethyl ) sulfinyl ] acetamide ) novel wake- vigilance- promoting agent chemically pharmacologically dissimilar CNS stimulant amphetamine , methylphenidate , pemoline . It well tolerate low abuse liability compare CNS stimulant . Modafinil FDA approve variety sleep disorder , may relieve methamphetamine withdrawal symptom , improve cognitive function , show reduce cocaine use dependent user , safe co-administered intravenous methamphetamine . We conduct pilot , open-label clinical trial modafinil establish safety efficacy pharmacotherapy methamphetamine dependence . Specific Aims : 1 . Determine safety modafinil treatment methamphetamine dependence . 2 . Determine efficacy modafinil treatment methamphetamine dependence . 3 . Assess effect modafinil cognitive function methamphetamine user . 4 . Assess effect modafinil methamphetamine withdrawal symptom . 5 . Compare validity cellular telephone-based reporting system assess medication regimen adherence conventional electronic medication monitoring . Hypotheses : 1 . Modafinil safe well tolerate placebo comparison group another study . 2 . Subjects give modafinil use less methamphetamine subject give placebo . 3 . Subjects give modafinil demonstrate improvement cognitive function compare subject give placebo . 4 . Subjects give modafinil reduce withdrawal symptom compare subject give placebo . 5 . Adherence record accurately cellular telephone conventional electronic medication monitoring .</brief_summary>
	<brief_title>A Pilot Trial Modafinil Treatment Methamphetamine Dependence</brief_title>
	<detailed_description />
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<criteria>Age 18 50 year Patient agreeable condition study sign consent form Fluency English Contact site additional information .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>amphetamine</keyword>
	<keyword>methamphetamine</keyword>
	<keyword>addition</keyword>
	<keyword>treatment study</keyword>
	<keyword>drug use</keyword>
	<keyword>modafinil</keyword>
</DOC>